Navigation Links
Mindray Medical Provides Mid-Year Update on Product Development

SHENZHEN, China, July 19 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced updates on new product launches for the first half of 2010.

In the first half of the year, the company successfully released a total of four products across its three product lines. These include: a lower-end surgical bed, an additional advanced biochemistry analyzer; a feature-enhanced hand-carried color ultrasound system; and a new digital radiography system model. Full product descriptions are provided below.

"We are excited about the progress we have made with the addition of these four new products," commented Mr. Li Xiting, Mindray's president and co-chief executive officer. "Mindray continues to be aggressive in bringing its high-quality, competitively-priced products to market. A strong R&D initiative is an integral part of Mindray's strategy to maintain competitive advantage and generate additional revenue from new market opportunities. We are pleased with the current development of our product lines and are well-positioned to meet our goal of launching an additional seven to nine products in 2010."


    Patient Monitoring and Life Support
    -- HyBase 1000 - is a lower-end surgical bed that provides maximum comfort
       and great convenience to end-users, can suit various surgical
       disciplines, and offers a full-safety guarantee.

    In-Vitro Diagnostic Products
    -- BS-800 - is the newest high-level instrument from Mindray. This model
       not only provides superior performance and reliability, but is also
       innovative in structure, function, and application.

    Medical Imaging System
    -- M-7 - is an upgraded hand-carried color ultrasound system which
       received both the CE mark and FDA approval. A winner of the prestigious
       2010 Reddot design award, M7 is a productivity power station designed
       to meet current and future customer needs. With its sharp and clear
       image quality, M-7 can be used for diagnoses across a broad spectrum,
       including the abdominal, vascular and cardiac specialties. M7 enables
       clinicians to achieve an enhanced level of diagnostic confidence and

    -- DigiEye 760 - is the second model in Mindray's Digital Radiographic
       System and mainly consists of an FPD (flat-panel detector), X-ray
       generator, X-ray tube, mobile patient table, ceiling suspension and
       integrated workstation with the most advanced and innovative software

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global operational headquarters in Shenzhen, China, and multiple sales offices in major domestic and international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit .

    For investor and media inquiries please contact:

    In the U.S.:

     John Capodanno
     Tel:   +1-212-850-5705

     Bryan Armstrong
     Tel:   +1-312-553-6707

    In China:

     May Li
     Mindray Investor Relations
     Tel:   +86-755-2658-2518

SOURCE Mindray Medical International Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
2. Mindray Medical to Present at J.P. Morgan China Conference 2010
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Globus Medical Raises $110 Million in Series E Financing Round
7. Quark Pharmaceuticals Appoints New Chief Medical Officer
8. Boston University Biomedical Engineers Find Chink in Bacterias Armor
9. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
10. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from reveals that behind the ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s ... the world, and the most handsome men, look naturally attractive. Plastic surgery should ...
Breaking Medicine News(10 mins):